Sunish Shah retweeted
🆕🔥🟢FAST-ROCKET
A multicenter, retrospective study(N:639)
The first study to compare clinical outcomes between patients who received cefepime & meropenem in a subset of patients with AmpC-ECK E bacteremia expressing baseline ceftriaxone resistance(MIC > 1 µg/mL)
🔺Among patients infected by ceftriaxone-resistant AmpC-E, carbapenems were used as definitive treatment in 30% (65/214), while cefepime was used for definitive treatment in 41% (88/214)
🔺After propensity score weighting, no statistically significant difference in 30-day mortality (HR, 1.08; 95% CI, 0.49–2.39; P= 0.848) was observed between patients infected by ceftriaxone-resistant AmpC-ECK E who received definitive treatment with meropenem or cefepime #IDXposts
sciencedirect.com/science/ar…
Sunish Shah retweeted
🆕⚡Evaluating hypoalbuminaemia thresholds associated with delayed blood sterilization among patients receiving cefazolin or antistaphylococcal penicillins for MSSA bacteraemia
After propensity score weighting, patients with an albumin level of ≤3.0 g/dL had a significantly slower time to blood culture sterilization compared with patients with albumin levels >3 g/dL (HR = 0.6; 95% CI: 0.44–0.81; P < 0.01) @DrToddLee #IDXposts
Among the 461 patients screened, 285 patients met the inclusion criteria; 34% (97/285) were people who inject drugs and 45% (130/285) had definite endocarditis . #IEWiki academic.oup.com/jac/article…
Sunish Shah retweeted
From our issue: Dr. Sunish Shah discusses non–carbapenemase-producing carbapenem-resistant Enterobacterales including its epidemiology, treatment guideline recommendations, and clinical studies around therapies. #IDtwitter #MedTwitter
contagionlive.com/view/a-no-…
Sunish Shah retweeted
Our last virtual open house for our PGY2 in ID at YNHH of the recruitment season is this Wed. (12/18)!
Use the link below to register and learn more about our great hospital and amazing program!! 🤓💊🧫
#ynhhspharmacy #idpharmd #pharmacyresidency #pgy2 #pharmacyx #MedTwitter
🚨 🚨 We are recruiting for a PGY2 Pharmacy Resident in Infectious Diseases @YNHH in New Haven, CT.
Learn more by joining one of our open houses. Register: surveymonkey.com/r/VWBZQKD or QR below and zoom link will be emailed prior to the session.
Sunish Shah retweeted
🆕️✨️The largest study to date of patients with Bacteroides spp. Bacteremia
Metronidazole 500mg q12h dosing was not associated with worse outcomes compared to metronidazole 500mgq8h
500mgq12h works for bactremia. It works for other infections, too
sciencedirect.com/science/ar…
You can dose metronidazole at 500 mg every 12 hours based on this analysis of 242 patients with Bacteroides bacteremia
It took us 6 years to finish so give it a read!
sciencedirect.com/science/ar…
1
104
Sunish Shah retweeted
🆕️⚡️⚡️Retrospective Study #AAC
Real world data
Incidence of serotonin syndrome in patients receiving tedizolid and concomitant serotonergic agents #IDXpost
Linezolid vs. Tedizolid?
journals.asm.org/doi/10.1128…
Sunish Shah retweeted
Carbapenem combination resulted in faster blood culture sterilization for MSSA by 25 h compared to matched controls, but no differences in mortality:
doi.org/10.1093/jac/dkae198
@shahnanigans1 @ryanshields @OUPMedicine @OxfordJournals #JACNews
Sunish Shah retweeted
The largest study of Pseudomonas endocarditis to date
🆕️🔥#JAC @Shahnanigans1 @ryankshields
Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis
Combination therapy did not improve clinical outcomes
#IDXposts #IEwiki academic.oup.com/jac/article…
Sunish Shah retweeted
🆕️🔥Multicentre, retrospective study #JAC @Shahnanigans1 @ryankshields
Carbapenem *+ cefaz or ASPs resulted in faster time to blood culture sterilization,but NO DIFFERENCES in overall MORTALITY rates in patients with persistent MSSA bacteraemia [>48 h] academic.oup.com/jac/article…
academic.oup.com/jac/advance…
^here was the answer (kinda/sorta)
#idtwitter If you had a 35 year old PWID with a 2 cm TV vegetation /pulmonary emboli due to mssa that is failing to clear blood cultures after 5 days of cefazolin, what would you do?
@MK_IDpharm @IdVilchez @MDPharmDMVP
have thought about this so I hope they don’t mind my tags
15%continue cefazolin
41%add ertapenem
32%switch to oxacillin
12%use a different regimen
268 votes • Final results 1
135
Among patients with MDR PSAR bacteremia or pneumonia, we found a higher rate of treatment emergent resistance due to ceftazidime avibactam compared to ceftolozane tazobactam
academic.oup.com/cid/advance…
217
Sunish Shah retweeted
🆕️⚡️⚡️ @CIDJournal
Rates of resistance to ceftazidime-avibactam and ceftolozane-tazobactam among patients treated for multidrug-resistant Pseudomonas aeruginosa bacteremia or pneumonia #idxposts academic.oup.com/cid/article…
Sunish Shah retweeted
🆕#Breakpoints Episode:
Drs. Nicolas Torney & Sunish Shah join Dr. Jeannette Bouchard (@jlbouchard001) to discuss our next topic in our Dosing Consult series: BID vs TID dosing for metronidazole. Dive ➡️PK/PD & real-world application of this switch!
🎧 sidp.pinecast.co
Sunish Shah retweeted
🏥#MedTwitter...COMING Mon, 10/30
📝How to best use Paxlovid in Outpt setting w/⭐️@NatashaBhuyan & Me + @BonumCE
Supported by an edu grant from @Pfizer
🟢Answer PRE-polls👇
🗓️Watch video Mon
🔴Answer post-polls
🏆Claim 🆓 #CME👉bit.ly/sim-pax
1⃣st: Tell us who u are
83%Pharmacist
17%ID MD/DO
0%GP FP PCP MD/DO
0%APP, RN, Other HCP
41 votes • Final results#idtwitter If you had a 35 year old PWID with a 2 cm TV vegetation /pulmonary emboli due to mssa that is failing to clear blood cultures after 5 days of cefazolin, what would you do?
@MK_IDpharm @IdVilchez @MDPharmDMVP
have thought about this so I hope they don’t mind my tags
15%continue cefazolin
41%add ertapenem
32%switch to oxacillin
12%use a different regimen
268 votes • Final results Sunish Shah retweeted
The largest series of Serratia endocarditis to date!
🆕️⚡️#JAC
@Shahnanigans1
Serratia endocarditis: antimicrobial management strategies and clinical outcomes
Combination antibiotic treatment was associated with improved outcomes
#IDXposts #IEWiki academic.oup.com/jac/article…
Sunish Shah retweeted
“This case series is in alignment with previous studies that suggest low risk of cross-reactivity between fluoroquinolones”
Read the article by Adams & Shah:
doi.org/10.1093/jac/dkad136
#JACNews
Amphotericin B has been recommended for Malassezia bloodstream infections. However, we took a look at our cases and found posaconazole may be a reasonable substitute.
sciencedirect.com/science/ar…
136
In our study of patients with a FQ allergy and administration of a different fluoroquinolone, we found the reaction risk occurred with a challenge to moxifloxacin (2/19; 9.5%), followed by ciprofloxacin (6/89; 6.3%), and levofloxacin (1/44; 2.2%). journals.asm.org/eprint/4MT2…











